{"title":"意大利肛门腺癌的管理:由意大利放射治疗和临床肿瘤协会(AIRO)胃肠道肿瘤研究组进行的全国调查","authors":"Pittoni P, Franco P, Caravatta L, Chiloiro G, Gambacorta MA, Genovesi D, Lupattelli M, Mantello G, Montesi G, Montrone S, Valvo F, Scandolaro L","doi":"10.47829/coo.2023.62401","DOIUrl":null,"url":null,"abstract":"Aims: Anal canal adenocarcinoma is a rare neoplasm and there is currently no consensus on optimal management. Indeed, some clinical studies support trimodal therapy","PeriodicalId":92766,"journal":{"name":"Clinics of oncology","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of Anal Adenocarcinoma in Italy: National Survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Tumors Study Group\",\"authors\":\"Pittoni P, Franco P, Caravatta L, Chiloiro G, Gambacorta MA, Genovesi D, Lupattelli M, Mantello G, Montesi G, Montrone S, Valvo F, Scandolaro L\",\"doi\":\"10.47829/coo.2023.62401\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims: Anal canal adenocarcinoma is a rare neoplasm and there is currently no consensus on optimal management. Indeed, some clinical studies support trimodal therapy\",\"PeriodicalId\":92766,\"journal\":{\"name\":\"Clinics of oncology\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics of oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47829/coo.2023.62401\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics of oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47829/coo.2023.62401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Management of Anal Adenocarcinoma in Italy: National Survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Tumors Study Group
Aims: Anal canal adenocarcinoma is a rare neoplasm and there is currently no consensus on optimal management. Indeed, some clinical studies support trimodal therapy
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
